Cabasag, Jose S.

HRN: 24-12-44  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/19/2023
METRONIDAZOLE 500MG (TAB)
11/19/2023
11/26/2023
ORAL
500mg
TID
Amoebiasis
Waiting Final Action 
11/19/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
11/19/2023
11/26/2023
IVTT
500mg
TID
Amoebiasis
Waiting Final Action 
11/20/2023
METRONIDAZOLE 500MG (TAB)
11/20/2023
11/26/2023
PO
500MG
BID
Amoebiasis; Intraabdominal Infection
Waiting Final Action 
11/20/2023
CIPROFLOXACIN 500MG (TAB)
11/20/2023
11/26/2023
PO
500MG
BID
Amoebiasis; Intraabdominal Infection
Waiting Final Action 
11/21/2023
METRONIDAZOLE 500MG (TAB)
11/21/2023
11/28/2023
PO
750mg
TID
Amoebiasis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: